Ep Wealth Advisors, LLC Pfizer Inc Transaction History

Ep Wealth Advisors, LLC

$11.3 Billion
Q3 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 316,905 shares of PFE stock, worth $7.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

316,905

Previous 335,241 5.47%

Holding current value

$7.9 Million

Previous $9.38 Million 2.23%

% of portfolio

0.08%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $507,907 - $575,567	-18,336 Reduced 5.47%	316,905 $9.17 Million
Q2 2024 Aug 19, 2024	SELL	$25.26 - $29.6 $20,738 - $24,301	-821 Reduced 0.24%	335,241 $9.38 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $74,148 - $85,146	2,864 Added 0.86%	336,062 $9.33 Million
Q4 2023 Feb 28, 2024	SELL	$26.13 - $33.94 $755,888 - $981,816	-28,928 Reduced 7.99%	333,198 $9.59 Million
Q3 2023 Nov 22, 2023	BUY	$32.09 - $37.51 $11.5 Million - $13.5 Million	358,876 Added 11042.34%	362,126 $12 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $10.4 Million - $12 Million	-286,701 Reduced 98.88%	3,250 $119,000
Q1 2023 Jun 05, 2023	BUY	$39.39 - $51.28 $5.64 Million - $7.35 Million	143,256 Added 97.66%	289,951 $11.8 Million
Q4 2022 Jun 12, 2023	SELL	$41.75 - $54.5 $5.4 Million - $7.05 Million	-129,337 Reduced 44.61%	160,614 $8.23 Million
Q3 2022 Dec 02, 2022	BUY	$43.76 - $53.42 $1.71 Million - $2.08 Million	38,973 Added 36.18%	146,695 $6.42 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $540,725 - $641,130	11,621 Added 12.09%	107,722 $5.65 Million
Q1 2022 May 20, 2022	SELL	$45.75 - $56.69 $180,255 - $223,358	-3,940 Reduced 3.94%	96,101 $4.98 Million
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $150,363 - $222,888	3,639 Added 3.77%	100,041 $5.91 Million
Q3 2021 Nov 23, 2021	BUY	$39.25 - $50.42 $3.56 Million - $4.57 Million	90,639 Added 1572.77%	96,402 $4.15 Million
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $3.67 Million - $4.71 Million	-93,456 Reduced 94.19%	5,763 $4.15 Million
Q2 2021 Aug 24, 2021	BUY	$35.91 - $40.68 $16,662 - $18,875	464 Added 0.47%	99,219 $3.89 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $83,791 - $94,500	2,502 Added 2.6%	98,755 $3.58 Million
Q4 2020 Feb 18, 2021	BUY	$33.47 - $42.56 $240,013 - $305,197	7,171 Added 8.05%	96,253 $3.54 Million
Q3 2020 Nov 17, 2020	BUY	$31.75 - $37.25 $114,839 - $134,733	3,617 Added 4.23%	89,082 $3.27 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $393,276 - $477,102	-13,057 Reduced 13.25%	85,465 $2.8 Million
Q1 2020 May 18, 2020	SELL	$27.03 - $38.62 $313,764 - $448,300	-11,608 Reduced 10.54%	98,522 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $735,432 - $834,622	22,340 Added 25.45%	110,130 $4.32 Million
Q3 2019 Nov 18, 2019	SELL	$32.49 - $42.13 $12,021 - $15,588	-370 Reduced 0.42%	87,790 $3.15 Million
Q2 2019 Aug 27, 2019	BUY	$36.98 - $41.52 $712,974 - $800,505	19,280 Added 27.99%	88,160 $3.82 Million
Q1 2019 May 20, 2019	BUY	$37.5 - $41.2 $179,325 - $197,018	4,782 Added 7.46%	68,880 $2.93 Million
Q4 2018 Feb 19, 2019	BUY	$38.47 - $43.86 $271,444 - $309,476	7,056 Added 12.37%	64,098 $2.8 Million
Q3 2018 Nov 15, 2018	BUY	$34.47 - $41.81 $1.1 Million - $1.34 Million	31,976 Added 127.57%	57,042 $2.51 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $59,858 - $63,815	1,815 Added 7.81%	25,066 $909,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $251,674 - $291,976	7,887 Added 51.33%	23,251 $825,000
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $1,529 - $1,623	46 Added 0.3%	15,364 $556,000
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $7,440 - $8,196	240 Added 1.59%	15,318 $547,000
Q2 2017 Aug 17, 2017	BUY	N/A	15,078	15,078 $506,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Pfizer Inc Transaction History